McKesson (MCK) Stock Could Be 43% Undervalued Despite Its $1.4B Infusion Deal

McKesson has been a powerful long term winner. With the share price now at US$938.84, the real question is whether the business can keep generating cash flows that line up with that kind of run. With a Discounted Cash Flow (DCF) view available, the focus turns squarely to what the current price implies about the money the company can return to shareholders over time. Over the past 5 years the stock has delivered a very large 379.8% return, which puts a lot of past optimism about McKesson's...